EOLS
Price:
$10.85
Market Cap:
$687.04M
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-02-08
Stock Exchange
NASDAQ
Ticker
EOLS
According to Evolus, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.47. This represents a change of -9.54% compared to the average of 2.73 of the last 4 quarters.
The mean historical Current Ratio of Evolus, Inc. over the last ten years is 3.65. The current 2.47 Current Ratio has changed 6.68% with respect to the historical average. Over the past ten years (40 quarters), EOLS's Current Ratio was at its highest in in the September 2018 quarter at 19.43. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
3.65
Median
2.17
Minimum
0.00
Maximum
17.88
Discovering the peaks and valleys of Evolus, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.17%
Maximum Annual Current Ratio = 17.88
Minimum Annual Increase = -96.01%
Minimum Annual Current Ratio = 0.00
Year | Current Ratio | Change |
---|---|---|
2023 | 2.33 | 7.41% |
2022 | 2.17 | -30.10% |
2021 | 3.10 | 337.97% |
2020 | 0.71 | -88.63% |
2019 | 6.23 | -65.17% |
2018 | 17.88 | 5.12% |
2017 | 0.34 | 10.17% |
2016 | 0.00 | -96.01% |
The current Current Ratio of Evolus, Inc. (EOLS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.53
5-year avg
2.91
10-year avg
3.65
Evolus, Inc.’s Current Ratio is greater than Collegium Pharmaceutical, Inc. (0.97), less than Phibro Animal Health Corporation (3.23), less than ANI Pharmaceuticals, Inc. (2.74), greater than Procaps Group S.A. (1.47), greater than Silver Spike Investment Corp. (0), greater than Eagle Pharmaceuticals, Inc. (1.70), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Prestige Consumer Healthcare Inc. (3.56), greater than Pacira BioSciences, Inc. (2.25), less than Intra-Cellular Therapies, Inc. (7.66), less than Alkermes plc (3.45), less than Amphastar Pharmaceuticals, Inc. (3.43), greater than Ascend Wellness Holdings, Inc. (1.47), less than Incannex Healthcare Limited (2.88), greater than Supernus Pharmaceuticals, Inc. (2.20),
Company | Current Ratio | Market cap |
---|---|---|
0.97 | $937.19M | |
3.23 | $876.50M | |
2.74 | $1.14B | |
1.47 | $279.80M | |
0 | $66.72M | |
1.70 | $6.74M | |
4.19 | $2.21B | |
3.56 | $3.89B | |
2.25 | $898.99M | |
7.66 | $9.04B | |
3.45 | $4.80B | |
3.43 | $1.84B | |
1.47 | $86.46M | |
2.88 | $30.87M | |
2.20 | $1.97B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evolus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evolus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Evolus, Inc.'s Current Ratio?
How is the Current Ratio calculated for Evolus, Inc. (EOLS)?
What is the highest Current Ratio for Evolus, Inc. (EOLS)?
What is the 3-year average Current Ratio for Evolus, Inc. (EOLS)?
What is the 5-year average Current Ratio for Evolus, Inc. (EOLS)?
How does the current Current Ratio for Evolus, Inc. (EOLS) compare to its historical average?